Kyung Dong Pharmaceutical Co (XKRX:011040) Buildings And Improvements : ₩67,196 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Kyung Dong Pharmaceutical Co Buildings And Improvements?

Kyung Dong Pharmaceutical Co's quarterly buildings and improvements increased from Sep. 2023 (₩67,086 Mil) to Dec. 2023 (₩67,086 Mil) and increased from Dec. 2023 (₩67,086 Mil) to Mar. 2024 (₩67,196 Mil).

Kyung Dong Pharmaceutical Co's annual buildings and improvements increased from Dec. 2021 (₩57,180 Mil) to Dec. 2022 (₩77,316 Mil) but then declined from Dec. 2022 (₩77,316 Mil) to Dec. 2023 (₩67,086 Mil).

Kyung Dong Pharmaceutical Co Buildings And Improvements Historical Data

The historical data trend for Kyung Dong Pharmaceutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyung Dong Pharmaceutical Co Buildings And Improvements Chart

Kyung Dong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

55,736.12

57,178.77

57,179.51

77,316.10

67,086.15

Kyung Dong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															77,316.29	75,809.99	67,085.96	67,086.15	67,196.33

Kyung Dong Pharmaceutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Kyung Dong Pharmaceutical Co (XKRX:011040) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyung Dong Pharmaceutical Co Ltd (XKRX:011040) » Definitions » Buildings And Improvements

Traded in Other Exchanges

N/A

Address

1926, Nambusunhwan-ro, Gwanak-gu, Seoul, KOR

Website

http://www.kdpharma.co.kr

Kyung Dong Pharmaceutical Co Ltd is a South Korea-based company engaged in the manufacturing and marketing of pharmaceutical products. Its products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases.

Kyung Dong Pharmaceutical Co (XKRX:011040) Headlines

No Headlines